No estrogen-like effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment

Journal of Steroid Biochemistry and Molecular Biology

Volumn 97, Issue 3, 2005, Pages 271-277

  Kretzschmar, Georg ^a   Nisslein, Thomas ^b   Zierau, Oliver ^a   Vollmer, Günter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Schaper & Brummer GmbH & Co KG   (Germany)

Author keywords

Cimicifuga racemosa; Gene expression; Phytoestrogen; Uterus; Vascular system

Indexed keywords

ANTIESTROGEN; FULVESTRANT; HERBACEOUS AGENT; RHIZOMA CIMICIFUGAE RACEMOSAE EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAVA VEIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ESTROGEN ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; MENOPAUSAL SYNDROME; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM; UTERUS;

2-PROPANOL; ANIMALS; CIMICIFUGA; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENE EXPRESSION; PHYTOESTROGENS; PLANT EXTRACTS; RATS; RATS, INBRED STRAINS; UTERUS; VENAE CAVAE;

ANIMALIA; CIMICIFUGA DAHURICA; CIMICIFUGA RACEMOSA; RHIZOMA;

EID: 27744531628     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.05.008     Document Type: Article

References (22)

1. G. Hernandez Munoz, and S. Pluchino Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer Maturitas 44 Suppl. 1 2003 59 65
2. W. Wuttke, D. Seidlova-Wuttke, and C. Gorkow The cimicifuga preparation BNO 1055 versus conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers Maturitas 44 Suppl. 1 2003 67 77
3. E. Liske Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders Adv. Ther. 15 1 1998 45 53
4. E.J. Kennelly, S. Baggett, P. Nuntanakorn, A.L. Ososki, S.A. Mori, J. Duke, M. Coleton, and F. Kronenberg Analysis of thirteen populations of black cohosh for formononetin Phytomedicine 9 5 2002 461 467
5. N. Einer-Jensen, J. Zhao, K.P. Andersen, and K. Kristoffersen Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats Maturitas 25 2 1996 149 153
6. O. Zierau, C. Bodinet, S. Kolba, M. Wulf, and G. Vollmer Antiestrogenic activities of Cimicifuga racemosa extracts J. Steroid Biochem. Mol. Biol. 80 1 2002 125 130
7. K. Hostanska, T. Nisslein, J. Freudenstein, J. Reichling, and R. Saller Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis Breast Cancer Res. Treat. 84 2 2004 151 160
8. V. Beck, E. Unterrieder, L. Krenn, W. Kubelka, and A. Jungbauer Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy J. Steroid Biochem. Mol. Biol. 84 2-3 2003 259 268
9. J.M. Sullivan, and L.P. Fowlkes The clinical aspects of estrogen and the cardiovascular system Obstet. Gynecol. 87 Suppl. 2 1996 36S 43S
10. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, and E. Vittinghoff Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group J. Am. Med. Assoc. 280 7 1998 605 613
11. J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, N.L. Lasser, M. Trevisan, H.R. Black, S.R. Heckbert, R. Detrano, O.L. Strickland, N.D. Wong, J.R. Crouse, E. Stein, and M. Cushman Estrogen plus progestin and the risk of coronary heart disease N. Engl. J. Med. 349 6 2003 523 534
12. J. Winer, C.K. Jung, I. Shackel, and P.M. Williams Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro Anal. Biochem. 270 1 1999 41 49
13. J.D. Fan, B.L. Wagner, and D.P. McDonnell Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity Mol. Endocrinol. 10 12 1996 1605 1616
14. S.A. Sundstrom, B.S. Komm, H. Ponce-de-Leon, Z. Yi, C. Teuscher, and C.R. Lyttle Estrogen regulation of tissue-specific expression of complement C3 J. Biol. Chem. 264 28 1989 16941 16947
15. P. Diel, R.B. Thomae, A. Caldarelli, O. Zierau, S. Kolba, S. Schmidt, P. Schwab, P. Metz, and G. Vollmer Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats Planta Med. 70 1 2004 39 44
16. U. Forstermann, J.P. Boissel, and H. Kleinert Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J. 12 10 1998 773 790
17. K.L. Chambliss, and P.W. Shaul Estrogen modulation of endothelial nitric oxide synthase Endocr. Rev. 23 5 2002 665 686
18. P. Diel, S. Schmidt, G. Vollmer, P. Janning, A. Upmeier, H. Michna, H.M. Bolt, and G.H. Degen Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens Arch. Toxicol. 78 4 2004 183 193
19. O. Zierau, R.B. Geis, S. Tischer, P. Schwab, P. Metz, and G. Vollmer Uterine effects of the phytoestrogen 6-(1,1-dimethylallyl)naringenin in rats Planta Med. 70 7 2004 590 593
20. D. Seidlova-Wuttke, O. Hesse, H. Jarry, V. Christoffel, B. Spengler, T. Becker, and W. Wuttke Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17β Eur. J. Endocrinol. 149 4 2003 351 362
21. J. Freudenstein, C. Dasenbrock, and T. Nisslein Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract Cancer Res. 62 12 2002 3448 3452
22. W.L. Kraus, and B.S. Katzenellenbogen Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists Endocrinology 132 6 1993 2371 2379